Answers are grounded in this paper and cite their sources.
Introduction Although smoking is a key modifiable risk factor for prostate cancer (PCa), its long-term impact on functional recovery remains under-researched. In this study, the association between baseline smoking status and 5-year longitudinal patient-reported functional outcomes was investigated in patients with localized PCa undergoing radical prostatectomy (RP) or radiotherapy (RT). Patients and Methods In this prospective study, 666patients (RP:n=327; RT:n=339) from a urological center were analyzed. The patients were categorized as never-smokers(nS), ex-smokers(eS), or active smokers(aS) at baseline. Validated EPIC-26 questionnaire was performed at diagnosis and annually for 60months. The primary outcomes were the longitudinal trajectories of urinary incontinence(UI) and sexual function, analyzed using linear mixed-effects models and also the interaction of smoking status with time as fixed effects. Results In the RP cohort, UI scores declined sharply in all groups at year 1 (mean:66), a significant divergence emerged by year 4: nS maintained superior function (mean:70; 95%confidence interval[CI]:65–75) compared with eS (mean:62;95%CI:6–69) and aS (mean:52; 95%CI:42–61). Active smokers experienced the most profound deterioration in the sexual domain, with no significant recovery through year 5. In the RT cohort, UI was preserved in nS and eS through year 2 (respective mean scores:84 and 83) but declined significantly in aS during this period (84 at baseline, 70 at year 2). Despite partial recovery by year 5, aS consistently reported the lowest UI scores. Sexual function declined significantly in all groups by year 1, then plateaued through year 5. Linear mixed-effects models confirmed aS as a significant driver of poor longitudinal trajectories for both treatment modalities. Conclusion Active smoking was significantly associated with poorer long-term functional recovery following definitive PCa treatment, particularly sexual function after RP and UI after RT. Clinical counseling should integrate pre-treatment smoking cessation interventions to mitigate quality of life deterioration and enhance functional outcomes.
No takes yet. Share an insight, caveat, or question.
Yeung et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: